10.8
CiteScore
 
5.3
Impact Factor
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Corrigendum
Current Issue
Editorial
Erratum
Full Length Article
Full lenth article
Letter to Editor
Original Article
Research article
Retraction notice
Review
Review Article
SPECIAL ISSUE: ENVIRONMENTAL CHEMISTRY
10.8
CiteScore
5.3
Impact Factor
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Corrigendum
Current Issue
Editorial
Erratum
Full Length Article
Full lenth article
Letter to Editor
Original Article
Research article
Retraction notice
Review
Review Article
SPECIAL ISSUE: ENVIRONMENTAL CHEMISTRY
View/Download PDF

Translate this page into:

Original article
2021
:14;
202103
doi:
10.1016/j.arabjc.2021.103007

Antidiabetic nephropathy effects of synthesized gold nanoparticles through mitigation of oxidative stress

Department of Endocrinology, Yunnan First People's Hospital, Kunming 650032, China
Department of Nephrology, Wenling First People's Hospital, Wenling 317500, China
Department of Nephrology, Yunnan First People's Hospital, Kunming 650032, China

⁎Corresponding authors at: Department of Nephrology, Wenling First People's Hospital, NO. 333, Chuanan South Road, Wenling 317500, China (L. Jiang). Department of Nephrology, Yunnan First People's Hospital, NO.157, Jinbi Road, Kunming 650032, China (J. Wang). ljiang.nephrology@yahoo.com (Liyan Jiang), w652124584@outlook.com (Jian Wang)

Disclaimer:
This article was originally published by Elsevier and was migrated to Scientific Scholar after the change of Publisher.

Abstract

Human proximal renal tubular epithelial cells (HK-2) are constantly exposed to glyco-oxidative injury due to the diabetic nephropathy. It has been reported that nanoparticles (NPs) due to their unique properties may show outstanding antioxidant activity. The influences of high glucose (HG) treatment with a concentration of 50 mM on HK-2 cells toxicity and the protective effects of synthesized gold NPs (AuNPs) by hydrothermal method were explored in terms of free radical production and advanced glycation end products (AGEs) formation. Also, the expression of Bax, Bcl-2, Caspase-3 at both mRNA and protein levels was evaluated by qPCR and ELISA assays, respectively followed by SIRT3 and SOD2 activity assays. It was observed that AuNPs with a diameter of about 30 nm and good colloidal stability at physiological pH attenuates HG‐induced cytotoxicity in HK-2 cells through a significant increase in cell viability and the reduction of free radical production, AGEs formation, and expression of Bax/Bcl-2 and Caspase-3 at both mRNA and protein levels. However, 3-TYP, a SIRT3 inhibitor, significantly inhibited the inhibitory effects of AuNPs on HG‐induced cytotoxicity. This data revealed that HG concentrations induced glyco-oxidative stress in kidney cells and AuNPs could be used as promising candidates in reducing the risk of progression of diabetic nephropathy.

Keywords

Gold
Nanoparticles
Diabetic nephropathy
High glucose
HK-2 cells
Antioxidant
1

1 Introduction

Diabetes is caused by insufficient secretion of insulin or lack of response of cells to this hormone. In this case, the body loses the ability to regulate blood sugar and generally it rises uncontrollably (Chikhi et al., 2014). The lack of controlling blood sugar causes damage to various parts of the body, including nerves and blood vessels (American Diabetes Association, 2004). Today, diabetes has attracted a lot of attention as a global pathology due to its complications and an integration of tubular, glomerular and vascular effects causing to diabetic nephropathy (Jensen and Deckert, 1992). Kidneys play an important role in filtering waste blood products and in conditions of high blood sugar are more sensitive than other tissue (Farokhi et al., 2013). On the other hand, diabetes mellitus is associated with oxidative stress, which is caused by an increase in free oxygen radicals, hydroxyl, or a decrease in the antioxidant defense system (Sklavos et al., 2010). Oxidative stress caused by high blood sugar in diabetes is also involved in the development of complications of diabetes, including nephropathy (Girard et al., 2014; Das and Sil, 2012). Hyperglycemia in diabetic patients causes the production of more reactive oxygen species (ROS) in the body (Furukawa et al., 2004). Previous studies have shown that oxidative stress plays an important role in the development of diabetes, and mitochondria have been suggested as the most important target in this toxicity, and damage to mitochondria can lead to exacerbation of oxidative stress and cell death (Jang et al., 2000). Mitochondria are the main source of ROS production in cells through the respiratory chain and are known as the main cause of hyperglycemic damage. Oxidative stress and increased production of ROS in the mitochondria and eventually apoptosis result in cell death (Sun et al., 2012).

Diabetic nephropathy is known to cause 14% of deaths due to diabetes and 40% of renal failure (Arumugam et al., 2014; Jain et al., 2014). Diabetes causes nephropathy with changes in both the glomerular and tubular parts of the kidneys. The most important lesions of diabetic nephropathy in the glomerular part of the kidney are sclerosis, mesenteric matrix diffusion and thickening of the basement membrane (Wang et al., 2014). Numerous biochemical and molecular factors such as: hyperglycemia, increased serum concentration of Advanced glycation end products (AGEs), oxidative stress, protein kinase C, inflammation, etc. have been identified in diabetic nephropathy. However, the lack of identification of the exact molecular mechanism of this disease has caused challenges in its treatment (Fioretto and Mauer, 2007; Sun et al., 2013).

Physiologically, some endogenous antioxidant molecules such as superoxide dismutase, glutathione peroxidase, catalase, and bilirubin reductase prevent oxidative stress-induced renal cell damage (Krishan and Chakkarwar, 2011). But free radical production in diabetic patients increases and subsequently reduces the antioxidant levels in the body, which result in a series of reactions involved in lipid peroxidation, protein oxidation, and cell damage and tissue damage.

Therefore, one of the effective and economical ways to better control the hyperglycemia effects is to neutralize the high levels of ROS produced using antioxidants that are safe and easily absorbed by the cellular system.

In recent years, we have witnessed the introduction of several nanoparticles (NPs) with hypoglycemic properties. However, there are still few studies to investigate the effectiveness of these particles on other complications of diabetes, including nephropathy (Daisy and Saipriya, 2012; Zhang et al., 2017; Deng et al., 2019). Among the medicinal NPs with hypoglycemic properties, we can mention gold (Au) NPs and their various derivatives (Daisy and Saipriya, 2012; Zhang et al., 2017; Deng et al., 2019; Ehsan et al., 2012; Al-Azzawie and Yaaqoob, 2016; Edrees et al., 2017; Ponnanikajamideen et al., 2019). It has been reported that AuNPs can mimic the activity of both superoxide dismutase and catalase. The number of studies on the effects of AuNPs on the complications of diabetes is very limited and since the prevalence of diabetes in the world has been very significant over the past two decades (Nair, 2007; Walker et al., 2020), more studies should be done on the effects of AuNPs. Because the long-term consequences of diabetes, in addition to the high costs imposed on the treatment system, overshadow the quality of life of individuals.

Therefore, in this study, we investigated the protective effect of AuNPs in preventing oxidative stress and oxidative damage in high glucose (HG)-induced oxidative stress in human kidney (HK-2) cells.

2

2 Materials and methods

2.1

2.1 Materials

HAuCl4, dodecyl trimethylammonium bromide (DTAB), Dulbecco’s modified Eagle’s medium (DMEM), and fetal bovine serum (FBS) were purchased form Sigma Co. (USA). All other materials were of analytical grade.

2.2

2.2 Synthesis of AuNPs

AuNPs were fabricated through a hydrothermal method. Briefly, 50 mL aqueous solutions of a fixed concentrations of DTAB (2.5 mM) were mixed with 1 mL of HAuCl4 1with a concentration 10 mM and 200 µL of aqueous solution of sodium citrate with a concentration of 200 mM. Afterwards, the solution was mixed and added into autoclaves and the samples were heated up to 150 °C for 10 h at 110 °C followed by centrifugation at 10,000 rpm for 40 min. The samples were finally washed with deionized water for three times.

2.3

2.3 Characterization of AuNPs

The diameter and morphology of as-synthesized AuNPs were characterized by TEM (EM10C, 100 KV, Zeiss, Germany) study. The samples were dissolved in ethanol and sonicated for 15 min. Afterwards, and a drop of the sample was deposited on a carbon-coated copper grid and allowed to be dried in air. The crystalline pattern of as-fabricated AuNPs (0.1 g) was explored by X-ray defecation (XRD) (Philips PW 1730, Amsterdam, Netherlands). The hydrodynamic radius and zeta potential values of AuNPs were also assessed by employing dynamic light scattering (DLS) [Brookhaven instruments 90Plus particle size/zeta analyzer (Holtsville, NY, USA)]. All experiments for DLS analysis were done in distilled water and the pH of the medium was adjusted using 0.1 M NaOH and 0.1 M HCl.

2.4

2.4 Cell culture

The human renal tubular epithelial cell line (HK-2) was cultured in DMEM, supplemented with D-glucose (5.5 mM), FBS (10%), penicillin (100 U/ml), and streptomycin (100 μg/ml) (Sigma, USA) in a 5% CO2 incubator at 37 °C. After pretreatment of cells with AuNPs (5 µg/ml) for 24 h, 50 mM glucose (HG) was added to the samples and incubation was continued for another 24 h. Vitamin C (Vit C) with a concentration of 5 µg/ml was used as the positive control. Also, for MTT assay, the number of cells was 1 × 104 and the for the rest of experiments the number of cells was 1 × 106.

2.5

2.5 MTT assay

Cell viability was done by the MTT assay through reading the absorbance of the samples at 570 nm using a microplate reader (BIO-RAD microplate reader-550). Briefly, the treated samples were mixed by MTT stock solution (5 mg mL−1) for 4 hr. After removing the supernatants, 150 μL DMSO solution was added for 2 min and the absorbance of the samples was then read. The data were expressed in comparison with negative control cells.

2.6

2.6 Reactive oxygen species (ROS) assay

The generation of intracellular ROS was investigated through the dichlorodihydrofluorescein diacetate (DCFH-DA) assay. Briefly, the treated cells were washed and incubated with a DCFH-DA probe (20 μM) for 30 min. Then, the fluorescence intensity of the samples was measured at λexem of 485 nm/530 nm using a spectrofluorometer (Gemini EM). The fluorescence images were taken employing a Zeiss fluorescence microscope (Zeiss, Germany).

2.7

2.7 Quantitative PCR (qPCR) analysis

The expression level of Bax, Bcl-2, and Caspase-3 mRNA was evaluated using qPCR technique. The total RNAs of cells were extracted using the RNA Isolation Kit (Roche Life Science) followed by quantification assays using a UV-3600 spectrophotometer (Shimadzu, Japan). Afterward, cDNA was done with 1 µg RNA and a first strand cDNA synthesis kit (Fermentas, Thermo scientific, USA) according to manufacturer’s protocols. The qPCR assay was carried out using SYBR Green bonding with an qPCR system (San Diego, CA 92122, USA). Quantitative gene expression was assessed by comparative CT (ΔΔCT) method (Schmittgen and Livak, 2008), using GAPDH as a housekeeping control gene.

2.8

2.8 Protein extraction

Protein was extracted from cells using a mild lysis buffer, including 50 mM Tris-HCl pH 8, 100 mM NaCl, 1.2 mM DTT, 4 mM MgCl2, 0.5 mM EDTA, 7% glycerol, and 0.1% triton). The protein concentration was then calculated using the Bradford assay (Gotham et al., 1988).

2.9

2.9 ELISA assay

The level of AGE, and expression of Bax, Bcl-2 and Caspase-3 proteins were determined using ELISA assay using AGE Assay Kit (ab238539), human Bax ELISA Kit (ab199080), human Bcl-2 ELISA Kit (ab119506), and human Caspase-3 ELISA Kit (ab181418), respectively. After addition of the primary and secondary antibody, the final step was done by adding 100 µL stop solution and the absorbance was read at 450 nm using a microplate reader (BIO-RAD microplate reader-550).

2.10

2.10 SOD2 activity

Quantification of SOD2 activity in the cell was done using SOD Activity Kit StressXpress® (SKT-214) based on the manufacturer’s instructions. Briefly, after treatment of the cells and sample preparation, the substrate was added followed by xanthine oxidase reagent and incubated at room temperature for 20 min. The colored product was read at 450 nm using a microplate reader (BIO-RAD microplate reader-550).

2.11

2.11 SIRT3 activity

SIRT3 activity was determined using the SIRT3 Activity Assay Kit (Fluorometric, ab156067). according to the manufacturer’s instructions. HK-2 cells were treated with or without 30 μM SIRT3 inhibitor (3-TYP) for 12 h followed by incubation with AuNPs for 24 h, and finally treated with 50 mM HG for another 24 h.

Briefly, after treatment of the cells and homogenization, the fluoro-substrate peptide as a substrate was mixed with lysed samples and the fluorescence intensity at 2 min interval was measured at λexem of 340–360 nm/440–460 nm using a spectrofluorometer (Gemini EM).

2.12

2.12 Statistical analysis

Statistical analysis was done using Student’s t-test and one-way analyses of variance (ANOVA) and post-hoc procedures based on Newman-Keuls tests. Results were expressed as means ± standard errors (SEs) of three (n = 3) independent experiments. P < 0.05 was considered significant.

3

3 Results

3.1

3.1 Synthesis and characterization of AuNPs

The AuNPs were synthesized by hydrothermal method and characterized by different approaches such as TEM, DLS, and XRD investigations. As shown in Fig. 1a, the as-synthesized AuNPs provide hexagonal shapes with a diameter of <30 nm. To discuss the colloidal stability of AuNPs, a DLS study was run to determine the hydrodynamic radius and zeta potential values. As depicted in Fig. 1b, the hydrodynamic radius of AuNPs was observed to be around 157.33 nm with a PDI of 0.294, revealing the good colloidal stability of AuNPs. Zeta potential value was determined to be around −35.66 mV, indicating the presence of a potential repulsive electrostatic force between the NPs to limit the tendency of NPs to agglomeration. XRD study was also carried out to analyze the crystalline phase of fabricated NPs. ion was used to confirm the crystalline nature of the particles. Fig. 1c displayed a representative XRD pattern of the AuNPs fabricated by the hydrothermal method after the successful reduction of Au3+ to Au0. Several Bragg reflections were observed at 2ϴ = 37.99° (1 1 1), 44.02° (2 0 0), 63.11° (2 2 0) and 77.85° (3 1 1) which are in accordance with those reported for the standard AuNPs (Au0) (Joint Committee on Powder Diffraction Standards-JCPDS, USA). Thus, the XRD study indicated that the AuNPs were intrinsically crystalline.

TEM image (a), DLS histogram (b), and XRD pattern of as-synthesized AuNPs by hydrothermal method.
Fig. 1
TEM image (a), DLS histogram (b), and XRD pattern of as-synthesized AuNPs by hydrothermal method.

3.2

3.2 Colloidal stability of AuNPs

To measure the colloidal stability of AuNPs in the medium with different pH values and glucose concentrations, DLS study was run. It was shown that the AuNPs had the smallest hydrodynamic radius in the medium with a pH value of 7.5 (Fig. 2a) and glucose concentration of 1 mM (Fig. 2b). However, it was seen that the hydrodynamic radius of AuNPs was almost constant in the medium with glucose concentration in the range of 1–50 mM (Fig. 2b). Moreover, zeta potential study (Fig. 2c, d) showed the same trend with hydrodynamic radius analysis, indicating that different pH values and glucose concentrations changes the charge distribution on the surface of AuNPs and the charge distribution in a medium with pH value of 7.5 (Fig. 2c) and glucose concentrations with a range of 1 to 50 mM (Fig. 2d) was in the most optimum state.

DLS study of AuNPs in a medium with different pH values (a) and different glucose concentrations (b), zeta potential study of AuNPs in a medium with different pH values (c) and different glucose concentrations (d).
Fig. 2
DLS study of AuNPs in a medium with different pH values (a) and different glucose concentrations (b), zeta potential study of AuNPs in a medium with different pH values (c) and different glucose concentrations (d).

3.3

3.3 MTT assay

MTT assay was done to measure the vitality of HK-2 cells in the presence of varying concentrations of AuNPs ranging from 1 to 30 µg/mL for 48 h. As shown in Fig. 3a, the viability of cells remarkably decreased after addition of 10, 20, and 30 µg/mL of AuNPs for 48 h, however, AuNPs with concentrations of 1 and 5 µg/mL did not induce a remarkable change on the viability of HK-2 cells. Therefore, AuNPs with a concentration of 5 µg/mL was used to study the protective effect of AuNPs against HG-induced oxidative stress in HK-2 cells (Fig. 3 b). It was displayed that HG induced a remarkable decrease (***P < 0.001) in cell viability compared to the control group (Fig. 3b). However, pretreatment of the cells with AuNPs resulted in the significant recovery (##P < 0.01) of cell viability in comparison with HG-induced cell mortality. Also, it was shown that the protective effect of AuNPs was more pronounced (&P < 0.05) than Vit C (Fig. 3b). This data indicated that AuNPs can serve as potential agents in the protection of the cells against HG-stimulated stress.

Protective effect of AuNPs on HG-stimulated cytotoxicity in HK-2 cells. The cells were incubated with different concentrations (1–30 μg/ml) of AuNPs for 48 h (a). HK-2 cells were pretreated with a fixed concentration of AuNPs (5 μg/ml) for 24 h, and subsequently, the pretreated cells then were added by 50 mM glucose (HG) for an additional 24 h, and viability of cells was examined by MTT assay. Vit C (5 μg/ml) was used as the positive control. Data represent mean ± SEM. of three independent runs. *P < 0.05, **P < 0.01, ***P < 0.001 relative to control; #P < 0.05, ## P < 0.01 relative to HG- treated cells; &P < 0.05 relative to Vit C- treated cells.
Fig. 3
Protective effect of AuNPs on HG-stimulated cytotoxicity in HK-2 cells. The cells were incubated with different concentrations (1–30 μg/ml) of AuNPs for 48 h (a). HK-2 cells were pretreated with a fixed concentration of AuNPs (5 μg/ml) for 24 h, and subsequently, the pretreated cells then were added by 50 mM glucose (HG) for an additional 24 h, and viability of cells was examined by MTT assay. Vit C (5 μg/ml) was used as the positive control. Data represent mean ± SEM. of three independent runs. *P < 0.05, **P < 0.01, ***P < 0.001 relative to control; #P < 0.05, ## P < 0.01 relative to HG- treated cells; &P < 0.05 relative to Vit C- treated cells.

3.4

3.4 ROS assay

HG-stimulated intracellular ROS production was assessed in HK-2 cells using by a DCFH-DA assay. As exhibited in Fig. 4a, incubation with HG for 24 h caused an increase in DCF fluorescence intensity, which is related to the content of ROS produced. Indeed, the treatment of cells with HG significantly enhanced (***P < 0.001) intracellular ROS level in HK-2 cells (Fig. 4a) compared with the negative control cells. However, pretreatment with AuNPs potentially decreased (###P < 0.001) HG-induced ROS production, as indicated by the lower DCF fluorescence intensity in AuNPs pretreated cells (Fig. 4a). The data from fluorescence microscope also indicated that a significant increase in the ROS level was detected in HK-2 cells treated with HG relative to the control cells, whereas pretreatment with AuNPs determined a remarkable decrease in the number of green fluorescence cells as an indicator of ROS production (Fig. 4b). Therefore, these results indicated that protective effect of AuNPs against HG-triggered ROS production was more pronounced than Vit C.

AuNPs mitigate HG-induced ROS production in HK-2 cells. The cells were pretreated with AuNPs (5 μg/ml) for 24 h, and then were incubated with 50 mM HG for another 24 h. Intracellular ROS levels (a) and the fluorescence image of cells (b) were then determined by DCF fluorescence intensity. Vit C (5 μg/ml) was used as the positive control. Data represent means ± SEM, n = 3. ***P < 0.001 relative to control; ##P < 0.01, ##P < 0.01 relative to HG- treated cells; &P < 0.05 relative to Vit C- treated cells.
Fig. 4
AuNPs mitigate HG-induced ROS production in HK-2 cells. The cells were pretreated with AuNPs (5 μg/ml) for 24 h, and then were incubated with 50 mM HG for another 24 h. Intracellular ROS levels (a) and the fluorescence image of cells (b) were then determined by DCF fluorescence intensity. Vit C (5 μg/ml) was used as the positive control. Data represent means ± SEM, n = 3. ***P < 0.001 relative to control; ##P < 0.01, ##P < 0.01 relative to HG- treated cells; &P < 0.05 relative to Vit C- treated cells.

3.5

3.5 qPCR assay

To explore the protective mechanism of AuNPs on HG-induced apoptosis, the expression of Bax, Bcl-2, and Caspase-3 mRNAs were assessed by qPCR assay. Fig. 5 demonstrates the mRNA expression of Bax (Fig. 5a), Bcl-2 (Fig. 5b), and Caspase-3 (Fig. 5c) with or without AuNPs pretreatment in HK-2 cells exposed to 50 mM HG. It was observed that the pro-apoptotic Bax mRNA was remarkably increased (**P < 0.01) (Fig. 5a), while the anti-apoptotic Bcl-2 mRNA was decreased (**P < 0.01) by HG treatment (Fig. 5b), However, pretreatment with AuNPs significantly decreased Bax mRNA (##P < 0.01) and increased Bcl-2 mRNA (#P < 0.05) expressions. These data indicated that AuNPs inhibited HG-stimulated apoptosis by decreasing the ratio of Bax/Bcl-2. As the alterations of Bax/Bcl-2 levels result in the initiation of Caspase-dependent signaling pathways, we examined the Caspase-3 in this study. As depicted in Fig. 5c, compared to the control group, HG triggered a remarkable increase in the expression of Caspase-3 mRNA (**P < 0.01). However, AuNPs revealed a reduced level in the expression of Caspase-3 compared with the HG-treated group (#P < 0.05) (Fig. 5c). Also, it was shown the protective effects of AuNPs against HG-induced apoptosis was more pronounced than Vit C. These data determined that AuNPs reduced Caspase-3 expression to inhibit HG-induced apoptosis.

AuNPs reduce HG-induced apoptosis in HK-2 cells as determined by qPCR assay. The cells were pretreated with AuNPs (5 μg/ml) for 24 h and then were incubated with 50 mM HG for another 24 h. The expression level of Bax mRNA (a), Bcl-2 mRNA (b), and Caspase-3 mRNA were then explored by qPCR assay (a). Vit C (5 μg/ml) was used as the positive control. Data represent means ± SEM, n = 3. **P < 0.01 relative to control; #P < 0.05, ##P < 0.01 relative to HG- treated cells; &P < 0.05 relative to Vit C- treated cells.
Fig. 5
AuNPs reduce HG-induced apoptosis in HK-2 cells as determined by qPCR assay. The cells were pretreated with AuNPs (5 μg/ml) for 24 h and then were incubated with 50 mM HG for another 24 h. The expression level of Bax mRNA (a), Bcl-2 mRNA (b), and Caspase-3 mRNA were then explored by qPCR assay (a). Vit C (5 μg/ml) was used as the positive control. Data represent means ± SEM, n = 3. **P < 0.01 relative to control; #P < 0.05, ##P < 0.01 relative to HG- treated cells; &P < 0.05 relative to Vit C- treated cells.

3.6

3.6 ELISA assay

ELISA assay was done to assess the level of AGEs and Bax, Bcl-2 and Caspase-3 proteins. Fig. 6 shows that the level of AGEs (Fig. 6a), and expression of Bax (Fig. 6b), Bcl-2 (Fig. 6c) and Caspase-3 (Fig. 6d) proteins in the absence and presence of AuNPs pretreatment in HK-2 cells exposed to 50 mM HG. It was deduced that the level of AGEs (Fig. 6a) and the pro-apoptotic Bax protein (Fig. 6b) was significantly enhanced (***P < 0.001), however the level of anti-apoptotic Bcl-2 protein was reduced (***P < 0.001) after treatment of the HK-2 cells with HG. However, pretreatment with AuNPs remarkably reduced the levels of AGEs (Fig. 6a) and Bax protein and increased the level of Bcl-2 protein. These results also showed that AuNPs mitigated HG-stimulated glycation of proteins and apoptosis. Furthermore, as shown in Fig. 6d, compared to the control group, HG stimulated a significant enhancement in the expression of Caspase-3 protein (***P < 0.01). While, AuNPs induced a reduction in the level of Caspase-3 protein compared with the HG-treated sample (##P < 0.01) (Fig. 6d). Moreover, it was revealed the protective effects of AuNPs against HG-triggered production of AGEs and apoptosis was more significant than Vit C.

AuNPs mitigate HG-induced AGEs production and apoptosis in HK-2 cells as determined by ELISA assay. The cells were pretreated with AuNPs (5 μg/ml) for 24 h and then were incubated with 50 mM HG for another 24 h. The level of AGEs production (a), expression level of Bax protein (b), Bcl-2 protein (c), and Caspase-3 protein (d) were then explored by ELISA assay. Vit C (5 μg/ml) was used as the positive control. Data represent means ± SEM, n = 3. **P < 0.01 relative to control; #P < 0.05, ##P < 0.01 relative to HG- treated cells; &P < 0.05 relative to Vit C- treated cells.
Fig. 6
AuNPs mitigate HG-induced AGEs production and apoptosis in HK-2 cells as determined by ELISA assay. The cells were pretreated with AuNPs (5 μg/ml) for 24 h and then were incubated with 50 mM HG for another 24 h. The level of AGEs production (a), expression level of Bax protein (b), Bcl-2 protein (c), and Caspase-3 protein (d) were then explored by ELISA assay. Vit C (5 μg/ml) was used as the positive control. Data represent means ± SEM, n = 3. **P < 0.01 relative to control; #P < 0.05, ##P < 0.01 relative to HG- treated cells; &P < 0.05 relative to Vit C- treated cells.

3.7

3.7 Investigating the mechanism of protective effects of AuNPs

To examine the molecular mechanism involved in the protective effect of AuNPs against oxidative stress and mitochondria-mediated apoptosis, activity assay relevant to the SIRT3-SOD2 was analysed (Bagul et al., 2018; Zhou et al., 2019; Tang et al., 2020). Indeed, to explore the involvement of SIRT3 in the mitigation of HG-induced HK-2 cell death and induction of apoptosis by AuNPs, the SIRT3 inhibitor 3-TYP was utilized, and enzyme activity, cell viability, ROS production, and Caspae-3 assays were measured. The outcomes indicated that the addition of 3-TYP together with HG aggravated the enzyme inactivation (Fig. 7a, b), cell mortality (Fig. 7c), ROS production (Fig. 7d), and Caspae-3 activation (Fig. 7e) and almost inhibited the protective impacts of AuNPs on HG-induced cytotoxicity in HK-2 cells. Therefore, these data determined that 3-TYP addition dramatically inhibited the AuNPs-triggered increase of SIRT3 activity and the activity of the downstream protein SOD2, indicating that AuNPs alleviated HG-stimulated HK-2 cell mitochondria-dependent ROS production and apoptosis through SIRT3-dependent pathway.

AuNPs inhibit oxidative damage and mitochondria-mediated cell damage though the SIRT3-SOD2 signaling pathway. The effect of AuNPs on the SIRT3 activity (a) and SOD2 activity (b). The influence of AuNPs and cotreatment with 3-TYP on cell viability (c), ROS production (d), and Caspase-3 activity (e). Data are presented as the means ± SD (n = 3) and the data shown with the same letters are not significantly different (P < 0.05).
Fig. 7
AuNPs inhibit oxidative damage and mitochondria-mediated cell damage though the SIRT3-SOD2 signaling pathway. The effect of AuNPs on the SIRT3 activity (a) and SOD2 activity (b). The influence of AuNPs and cotreatment with 3-TYP on cell viability (c), ROS production (d), and Caspase-3 activity (e). Data are presented as the means ± SD (n = 3) and the data shown with the same letters are not significantly different (P < 0.05).

4

4 Discussion

SIRT3 has been revealed to play an important role in the regulation of mitochondrial activity and in the inhibition of stimulated oxidative stress in renal tubular epithelial cells (Jiao et al., 2016). It has been shown that pyrroloquinoline quinone provide a protective effect in HK-2 cells against HG-triggered oxidative stress and apoptosis through SIRT3 signaling pathway (Wang et al., 2019). It has been indicated that SIRT3 could induce its antioxidant capacity by activating SOD2 to regulate the cellular redox status (Clark et al., 2011). In HK-2 cells, the progressive accumulation of glucose due to diabetic nephropathy and corresponding generation of ROS causes production of AGEs, lipoperoxidation, membrane mitochondrial dysfunction, and apoptosis (Wang et al., 2019). SIRT3 could also inhibit cell apoptosis via mitigating ROS production and blocking the dysregulation of mitochondria (Jiao et al., 2016).

NPs have shown to induce stimulated oxidative stress through regulation of ROS generation in different kinds of cells (Chen et al., 2013; Ahn et al., 2019; Pujalté et al., 2011). Also, it has been shown that the reversal of induced nephrotoxicity can be done through functionalized selenium NPs by blocking ROS-mediated apoptosis (Sanna et al., 2014; Nakkala et al., 2015). Among different NPs, AuNPs due to their high biocompatibility, biodegradability, and stability have shown to be potential candidate in development of antioxidant platforms. For example, it has been shown that green synthesis of AuNPs could trigger some antioxidant and biological functions (Balasubramani et al., 2015 Vinosha et al., 2019; Rizwan et al., 2017). Moreover, it has been indicated that AuNPs mitigate HG-triggered oxidative stress and apoptosis through tuberin-mTOR/NF-κB pathways in macrophages (BarathManiKanth et al., 2010b). Furthermore, it has been shown that AuNPs influence the antioxidant status in some normal human cells (Daems et al., 2019). Recently, it was also indicated that AuNPs can show antioxidant effect via restraining hyperglycemic conditions in diabetic mice (Manna et al., 2019). On the basis of the above results and already published papers, we can suggest that the nephroprotective effect of NPs, and in particular AuNPs, may be associated with their antioxidant activity. Indeed, this data is consistent with previous papers that AuNPs could protect kidney cells from oxidative damage (Manna et al., 2019; Li et al., 2017).

Moreover, our present data has indicated that the blocking of SIRT3 pathway could accelerate oxidative stress in cells and exacerbate cell mortality; these outcomes are consistent with a previous report that determined that SIRT3 signaling ameliorates kidney injury (Li and Shah, 2003). The pharmacodynamic and pharmacokinetic of AuNPs may vary due to the difference in the physicochemical properties of AuNPs. Therefore, the bioavailability of synthesized AuNPs in plasma, urine, and tissues including the kidney should be explored in future studies. Meanwhile, the protective mechanisms of AuNPs should be examined both in vivo and in clinical trials.

Although the cellular-molecular mechanisms of diabetic neuropathy have not been fully elucidated, there is evidence of an increase in ROS associated with this phenomenon (Sengani, 2017). Given the high prevalence and side effects that diabetes has on the kidney cells, it is necessary to look for ways to control this disease and its side effects. On the other side, it has been well-documented that AuNPs affect the antioxidant status in normal human cells (BarathManiKanth et al., 2010a). Also, it has been reported that AuNPs show potential antioxidant indices in hyperglycemic rats (Alomari et al., 2020). Also, antioxidant effect of AuNPs have been displayed to restraint hyperglycemic conditions in diabetic rats (BarathManiKanth et al., 2010a). Furthermore, it has been reported that AuNPs provide some protective effects in a rat model of diabetic nephropathy (Alomari et al., 2020). Therefore, in this study we aimed to consider the antidiabetic nephropathy effects of synthesized AuNPs through mitigation of oxidative stress in HG-stimulated oxidative stress and apoptosis in HK-2 cells.

Accurate understanding of the adverse effects of neuropathy due to diabetic hyperglycemia and its relationship with physicochemical changes in cells, as well as the mechanism of action of drugs that have positive effects in preventing or inhibiting the progression and possible treatment of this complication requires further research.

5

5 Conclusion

In this study, the protective effects of synthesized AuNPs against oxidative stress-stimulated by HG in HK-2 cells as a model of diabetic nephropathy were assessed using multiple biological assays. The results show that AuNPs show a good colloidal stability at physiological pH and they remarkably were capable of reducing oxidative stress-induced cell damage and apoptosis. Further analysis indicated that the nephroprotective roles of AuNPs are exerted through the activation of the SIRT3-SOD2 signaling pathway. These data may pave the way for advancement of some NPs-based therapeutic platforms in the treatment of diabetic nephropathy.

Acknowledgements

This study was supported by Open Project of Yunnan Endocrine and Metabolic Disease Clinical Medical Center (NO.2020LCZXKF–NM05), and Health Internal Research Institute Project of Yunnan Province (NO.2014NS229)

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

  1. , , , . Assessing the antioxidant, cytotoxic, apoptotic and wound healing properties of silver nanoparticles green-synthesized by plant extracts. Mater. Sci. Eng., C. 2019;1(101):204-216.
    [Google Scholar]
  2. , , . Hypoglycemic and antioxidant effects of gold nanoparticals in alloxan-induced diabetes rats. Int. J. Res. Biotechnol. Biochem. 2016;6(1):12-20.
    [Google Scholar]
  3. , , , , , , , , . Gold nanoparticles attenuate albuminuria by inhibiting podocyte injury in a rat model of diabetic nephropathy. Drug Deliv. Translat. Res.. 2020;10(1):216-226.
    [Google Scholar]
  4. , . Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27(Suppl 1):S5-S10.
    [Google Scholar]
  5. , , , , , , . Comparative evaluation of torasemide and furosemide on rats with streptozotocin-induced diabetic nephropathy. Exp. Mol. Pathol.. 2014;97(1):137-143.
    [Google Scholar]
  6. , , , , , . SIRT-3 modulation by resveratrol improves mitochondrial oxidative phosphorylation in diabetic heart through deacetylation of TFAM. Cells.. 2018;7(12):235.
    [Google Scholar]
  7. , , , , , , , . Structural characterization, antioxidant and anticancer properties of gold nanoparticles synthesized from leaf extract (decoction) of Antigonon leptopus Hook. & Arn. J. Trace Elem. Med Biol.. 2015;1(30):83-89.
    [Google Scholar]
  8. , , , , , , , . Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice. J. Nanobiotechnol.. 2010;8(1):16.
    [Google Scholar]
  9. , , , , , , , . Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice. J. Nanobiotechnol.. 2010;8(1):16.
    [Google Scholar]
  10. , , , , , , . Cerium oxide nanoparticles protect endothelial cells from apoptosis induced by oxidative stress. Biol. Trace Elem. Res.. 2013;154(1):156-166.
    [Google Scholar]
  11. , , , , , . Antidiabetic activity of aqueous leaf extract of Atriplex halimus L. (Chenopodiaceae) in streptozotocin–induced diabetic rats. Asian Pac. J. Trop. Dis.. 2014;4(3):181-184.
    [Google Scholar]
  12. , , , , . Cerium oxide and platinum nanoparticles protect cells from oxidant-mediated apoptosis. J. Nanopart. Res.. 2011;13(10):5547.
    [Google Scholar]
  13. , , , , , , , , , . Gold nanoparticles affect the antioxidant status in selected normal human cells. Int. J. Nanomed.. 2019;14:4991.
    [Google Scholar]
  14. , , . Biochemical analysis of Cassia fistula aqueous extract and phytochemically synthesized gold nanoparticles as hypoglycemic treatment for diabetes mellitus. Int. J. Nanomed.. 2012;7:1189.
    [Google Scholar]
  15. , , . Taurine ameliorates alloxaninduced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats. Amino Acids. 2012;43(4):1509-1523.
    [Google Scholar]
  16. , , , , . Selenium-layered nanoparticles serving for oral delivery of phytomedicines with hypoglycemic activity to synergistically potentiate the antidiabetic effect. Acta Pharmaceutica Sinica B.. 2019;9(1):74-86.
    [Google Scholar]
  17. , , , . Hypoglycemic and anti-inflammatory effect of gold nanoparticles in streptozotocin-induced type 1 diabetes in experimental rats. Nanotechnology.. 2017;3:4.
    [Google Scholar]
  18. , , , , , . Efficacy of nanogold-insulin as a hypoglycemic agent. J. Chem. Soc. Pak.. 2012;34(2):365-370.
    [Google Scholar]
  19. , , , . Preventive effects of hydroalcoholic extract of Prangosferulacea(L.) Lindl.on kidney damages of diabetic rats induced by alloxan. J. Sharekord. Univ. Med. Sci.. 2013;14(6):72-81.
    [Google Scholar]
  20. Fioretto, P., Mauer, M., 2007. Histopathology of diabetic nephropathy. Semin Nephrol. 27(2), 195–207. 8- Schena, F.P., Gesualdo, L., 2005. Pathogenetic mechanisms of diabetic nephropathy. J. Am. Soc. Nephrol. 16(3 suppl 1), S30–S33.
  21. , , , , , , . Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest.. 2004;114(12):1752-1761.
    [Google Scholar]
  22. , , , , , , . Oxidative damage in diabetics: Insights from a graduate study in La Reunion University. Biochem. Mol. Biol. Educ.. 2014;42(5):435-442.
    [Google Scholar]
  23. , , , . The measurement of insoluble proteins using a modified Bradford assay. Anal. Biochem.. 1988;173(2):353-358.
    [Google Scholar]
  24. , , , , . Effects of Tephrosia purpurea and Momordica dioica on streptozotocininduced diabetic nephropathy in rats. Biomed. Preventive Nutrit.. 2014;4(3):383-389.
    [Google Scholar]
  25. , , , , , . Protective effect of boldine on oxidative mitochondrial damage in streptozotocininduced diabetic rats. Pharmacol. Res.. 2000;42(4):361-362.
    [Google Scholar]
  26. , , . Diabetic retinopathy, nephropathy and neuropathy. Generalized vascular damage in insulin-dependent diabetic patients. Hormone and metabolic research. Supplement Series.. 1992;1(26):68-70.
    [Google Scholar]
  27. , , , , , . Role of Sirtuin3 in high glucose-induced apoptosis in renal tubular epithelial cells. Biochem. Biophys. Res. Commun.. 2016;480(3):387-393.
    [Google Scholar]
  28. , , . Diabetic nephropathy: Aggressive involvement of oxidative stress. J. Pharm. Educ. Res.. 2011;2(1):35-41.
    [Google Scholar]
  29. , , . ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J. Am. Soc. Nephrol.. 2003;14(suppl 3):S221-S226.
    [Google Scholar]
  30. , , , , , , , , , , , . SIRT3-KLF15 signaling ameliorates kidney injury induced by hypertension. Oncotarget.. 2017;8(24):39592.
    [Google Scholar]
  31. , , , , , , , , , , , . Amelioration of diabetic nephropathy using pomegranate peel extract-stabilized gold nanoparticles: assessment of nf-κb and nrf2 signaling system. Int. J. Nanomed.. 2019;14:1753.
    [Google Scholar]
  32. , . Diabetes mellitus, Part 1: physiology and complications. Br. J. Nurs.. 2007;16(3):184-188.
    [Google Scholar]
  33. , , , , . Green synthesis of silver and gold nanoparticles from Gymnema sylvestre leaf extract: study of antioxidant and anticancer activities. J. Nanopart. Res.. 2015;17(3):151.
    [Google Scholar]
  34. , , , , . In vivo type 2 diabetes and wound-healing effects of antioxidant gold nanoparticles synthesized using the insulin plant Chamaecostus cuspidatus in albino rats. Can. J. Diabetes. 2019;43(2):82-89.
    [Google Scholar]
  35. Pujalté, I., Passagne, I., Brouillaud, B., Tréguer, M., Durand, E., Ohayon-Courtès, C., l'Azou, B., 2011. Cytotoxicity and oxidative stress induced by different metallic nanoparticles on human kidney cells. Particle Fibre Toxicol. 8(1),10.
  36. , , , , . Gold nanoparticles reduce high glucose-induced oxidative-nitrosative stress regulated inflammation and apoptosis via tuberin-mTOR/NF-κB pathways in macrophages. Int. J. Nanomed.. 2017;12:5841.
    [Google Scholar]
  37. , , , , , , , , , , . Single-step green synthesis and characterization of gold-conjugated polyphenol nanoparticles with antioxidant and biological activities. Int. J. Nanomed.. 2014;9:4935.
    [Google Scholar]
  38. , , . Analyzing real-time PCR data by the comparative C T method. Nat. Protoc.. 2008;3(6):1101.
    [Google Scholar]
  39. , . Identification of potential antioxidant indices by biogenic gold nanoparticles in hyperglycemic Wistar rats. Environ. Toxicol. Pharmacol.. 2017;1(50):11-19.
    [Google Scholar]
  40. , , , , , , . Redox modulation protects islets from transplant-related injury. Diabetes. 2010;59(7):1731-1738.
    [Google Scholar]
  41. , , , , . Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy. Biochem. Biophys. Res. Commun.. 2013;433(4):359-361.
    [Google Scholar]
  42. , , , , , , . Protective effects of Salvianolic acid B on Schwann cells apoptosis induced by high glucose. Neurochem. Res.. 2012;37(5):996-1010.
    [Google Scholar]
  43. , , , , , , , . Ginsenoside Rg1 protects against Sca–1+ HSC/HPC cell aging by regulating the SIRT1–FOXO3 and SIRT3–SOD2 signaling pathways in a γ–ray irradiation–induced aging mice model. Exp. Therapeutic Med.. 2020;20(2):1245-1252.
    [Google Scholar]
  44. , , , , , , , . Biogenic synthesis of gold nanoparticles from Halymenia dilatata for pharmaceutical applications: Antioxidant, anti-cancer and antibacterial activities. Process Biochem.. 2019;1(85):219-229.
    [Google Scholar]
  45. , , , , , , , , . Diabetes prevalence, incidence and mortality in First Nations and other people in Ontario, 1995–2014: a population-based study using linked administrative data. CMAJ. 2020;192(6):E128-E135.
    [Google Scholar]
  46. , , , , , , . Pyrroloquinoline quinine protects HK-2 cells against high glucose-induced oxidative stress and apoptosis through SIRT3 and PI3K/Akt/FoxO3a signaling pathway. Biochem. Biophys. Res. Commun.. 2019;508(2):398-404.
    [Google Scholar]
  47. , , , , , . The protective effect of fucoidan in rats with streptozotocin-induced diabetic nephropathy. Mar. Drugs. 2014;12(6):3292-3306.
    [Google Scholar]
  48. , , , , , , . Preparation and characterization of hypoglycemic nanoparticles for oral insulin delivery. Biomacromolecules. 2017;18(12):4281-4291.
    [Google Scholar]
  49. , , , , , , , , , . tert-Butylhydroquinone treatment alleviates contrast-induced nephropathy in rats by activating the Nrf2/SIRT3/SOD2 signaling pathway. Oxid. Med. Cell. Longevity. 2019;18:2019.
    [Google Scholar]
Show Sections